Pricing Research Archives - tHEORetically Speaking

Ongoing Medicare Privatization Will Hurt Pharma As Much As the IRA

Posted on September 14, 2023 by Michael Broder

The pharmaceutical industry is in a frenzy over the recently released list of the drugs subject to price negotiation under the Inflation Reduction Act of 2023 (IRA) and the Act’s potential impact on profits. But an even bigger force… Continue Reading →

MArS Supplier Spotlight

Posted on March 21, 2022 by tHEORetically Speaking

Supplier Spotlight® highlights the unique skill sets and service offerings from organizations who are part of our CONNECTED COMMUNITY™. Below is an interview with Market Access & Pricing Strategy (MArS), the German-speaking market access experts. Tell us about MArS Market Access… Continue Reading →